Johnson & Johnson’s TearScience acquisition leads 2017 ophthalmology news

From company mergers and business updates to clinical trial updates and FDA approvals, Healio.com/OSN covered a wide-range of ophthalmology-related news in 2017.
While Johnson & Johnson’s acquisition of TearScience was the most-read article of the year, the online readers of Ocular Surgery News also kept up with the newest surgical and pharmaceutical developments.
Here are 2017’s most-read ophthalmology articles:
 
1. Johnson & Johnson Vision to acquire TearScience
In August, Johnson & Johnson Vision announced the acquisition of TearScience.
“These solutions,

Full Story →